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ABSTRACT 
Objective: To evaluate the role of the involvement of white matter tracts in huntingtin gene mutation patients as a potential biomarker of 
the progression of the disease. Methods: We evaluated 34 participants (11 symptomatic huntingtin gene mutation, 12 presymptomatic 
huntingtin gene mutation, and 11 controls). We performed brain magnetic resonance imaging to assess white matter integrity using diffusion 
tensor imaging, with measurement of fractional anisotropy. Results: We observed a significant decrease of fractional anisotropy in the 
cortical spinal tracts, corona radiate, corpus callosum, external capsule, thalamic radiations, superior and inferior longitudinal fasciculus, 
and inferior frontal-occipital fasciculus in the Huntington disease group compared to the control and presymptomatic groups. Reduction of 
fractional anisotropy is indicative of a degenerative process and axonal loss. There was no statistically significant difference between the 
presymptomatic and control groups. Conclusion: White matter integrity is affected in huntingtin gene mutation symptomatic individuals, 
but other studies with larger samples are required to assess its usefulness in the progression of the neurodegenerative process.
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RESUMO 
Objetivo: Avaliar o envolvimento da substância branca (SB) cerebral em indivíduos com mutação do gene da huntingtina. Métodos: Foram 
avaliados 34 indivíduos: 11 com mutação do gene da huntingtina sintomática, 12 assintomáticos com mutação do gene da huntingtina e 
11 indivíduos controles. Realizamos ressonância magnética cerebral para avaliar a integridade da SB usando o tensor de difusão (DTI), 
com medição da anisotrofia fracionada (FA). Resultados: Observamos uma diminuição da FA no trato corticoespinhal, coroa radiada, corpo 
caloso (joelho, corpo e esplênio), cápsula externa, radiações talâmicas, fascículo longitudinal superior e inferior, e fascículo frontal-occipital 
inferior no grupo dos indivíduos com mutação sintomática. A redução da FA é indicativa de processo degenerativo e perda axonal. Não houve 
diferença estatística entre os grupos controle e pré-sintomático. Conclusão: Houve comprometimento da integridade da SB em indivíduos 
com mutação no gene da Huntingtina sintomática, mas outros estudos são necessários para avaliar a sua utilidade na progressão do 
processo neurodegenerativo.
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Huntington’s disease (HD) is  a genetic disorder char-
acterized  by  motor, psychiatric,  and  cognitive impair-
ments.  Understanding the pathophysiology of HD,  the role 
of the structures and pathways involved in its pathogen-
esis, as well as identification of relevant biomarkers, may 
pave the  way for better disease management and control. 
Neuroimaging techniques for HD evaluate structural, func-
tional, and metabolic changes1. 
Initially, structural imaging studies assessed the degree of 
striatum (caudate nucleus and putamen) atrophy in patients 
with HD, and it has been shown that atrophy of this area 
occurs up to 15 to 20 years before the HD onset2,3, presenting 
a pattern of rapid and almost linear impairment over time. 
However, the  degeneration of the brain in HD extends far 
beyond the striatum, involving both cortical and subcortical 
regions. The involvement of the cerebral cortex has been of 
particular interest because mutant huntingtin protein aggre-
gates concentrate beyond the striatum4. Neuroimaging tech-
niques have been used to evaluate structural, functional and 
metabolic changes in HD5,6.
Diffusion tensor imaging (DTI)  is a method that uses 
magnetic resonance imaging (MRI) to measure changes in 
tissue composition. Quantitative measures of DTI, such as 
fractional anisotropy (FA) and axial diffusivity (AD), provide 
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information about white matter integrity and  can evalu-
ate the architecture of gray matter. More specifically, FA mea-
sures the degree to which fibers in a given voxel are oriented 
in the same direction. Thus, a high FA indicates greater fiber 
organization. On the other hand, a reduced FA, such as that 
described in patients with HD6, suggests white matter degen-
eration. Specifically, a reduction in white matter volume 
may  suggest a  decrease in the number of axons within an 
affected region, a decrease in the amount of myelin surround-
ing axons, or both5. Moreover, damage of oligodendrocytes 
and axonal membranes, along with interrupted axonal trans-
port due to the presence of mutant huntingtin and increased 
microglia reactivity, have been described in the pathophysi-
ological context of HD and may be the cause of FA abnormal-
ities6. Finally, previous studies have shown that FA and AD 
are effective in analyzing cortex, striatum, and white matter 
microstructures in individuals with HD7,8. 
Kloppel et al. performed a study on FA maps to determine 
which voxels could correctly identify individuals as presymp-
tomatic mutation carriers or controls9. They found a reduc-
tion in connectivity between the caudate body and the fron-
tal cortex in presymptomatic patients.  This study was  the 
first to use DTI to identify possible biomarkers of HD, as well 
as to explore the structure-function relationship of brain 
regions in presymptomatic individuals with HD9. 
The observation that the loss of white matter and atro-
phy of the striatum correlate with motor and neuropsycho-
logical performance suggests that combined structural imag-
ing measures may be effective biomarkers of HD10. Moreover, 
a recent analysis (subgroup of TRACK-HD) showed that 
changes in white matter connections  of the sensorimo-
tor cortex are correlated with the phenotypic deterioration 
associated with HD, and that these changes could be used to 
estimate the imminent onset of symptoms in asymptomatic 
individuals with mutant huntingtin11. 
Although the diagnosis  of HD  is performed through 
a  molecular test, there is no marker for the progression  of 
symptoms, which would allow for the objective evaluation of 
drug efficacy and action in presymptomatic patients.
We aimed to evaluate  the use of DTI in the analysis  of 
white matter tracts as a potential biomarker of the progres-
sion  of the degenerative process in individuals with muta-
tions of the Huntington gene.
METHODS
The 40 participants selected for this study either had 
a family history of HD or exhibited symptoms that were 
strongly  indicative  of the disease. These individuals  were 
submitted to imaging studies and clinical evaluations, 
which included the Unified Huntington’s Disease Rating 
Scale –motor part, validated to the Portuguese language12,13; 
the Mini Mental State Examination14;  Montreal Cognitive 
Assessment; and the Beck Depression Scale15,16. Mean scores 
of the scales employed are shown in the Table. 
Of the 40 participants, four were excluded due to issues 
with imaging acquisition and two due to a further diagnosis 
of HD-like 2.
The remaining 34 participants underwent molecular test-
ing for HD. 
These 34 participants were divided into three groups: 
11 patients with symptomatic huntingtin gene mutation 
(Huntington’s disease); 12 individuals with presymptomatic 
huntingtin gene mutation (without behavioral symptoms, 
cognitive impairment, or abnormal involuntary movements, 
but with a positive test result) with a maximum score of 5 on 
the Unified Huntington’s Disease Rating Scale – motor part17; 
and 11 control individuals. The average duration of the dis-
ease in the HD group was 5.6 years (2–16 years). 
Ethics, consent and permissions
All patients were informed about the objective of the study 
and freely signed an informed consent form. This study was sub-
mitted to and approved by the Ethics Committee in Research 
of UNIFESP (CEP #1614/11) and all national specific laws on 
ethics in medical research have been observed. All subjects 
included in the research consented and allowed us to publish, 
in scientific meetings and journals, the results of this study.
Image acquisition and processing
Participants underwent a non-contrasted MRI scan 
of the brain for up to nine minutes to measure white mat-
ter parameters. Examinations were performed in a Siemens 
MAGNETOM ESPREE 1.5T scanner with  SyngoDTI tractog-
raphy. This technique uses diffusion tensor data, and allows 
for the three-dimensional viewing of specific white matter 
tracts. A gradient echo with an echo planar imaging readout 
Table. Clinical and demographic characteristics of the study participants. 
Variable  n / Sex  Age (in years)
Number of 
CAG repeats 
 MoCA 
score
 MMSE 
score
UHDRS 
motor score BDS
Controls 7F / 4M 33.1 17.9 27.5 29.5 0.72 8.9 
HD 6F / 5M 45.7 44.2 15.2 21.2 39 19.2 
Pre-symptomatic 6F / 6M 34.7 41.7 25.3 28.6 1.3 4.5 
Note: All subjects were heterozygous for Huntington’s disease (HD). F: Female; M: Male; MoCA: Montreal Cognitive Assessment; MMSE: mini-mental state 
examination; UHDRS: Unified Huntington’s Disease Rating Scale; BDS: Beck Depression Scale.
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sequence was applied in 30 directions, one b = 0.2-mm slices, 
and 30 × b = 900 s2/mm. The software used was  Syngo  DTI 
Evaluation  for the quantitative evaluation of the frequency 
and direction of water movement inside a voxel (2.3 mm), cal-
culation of different diffusion parameters based on specific 
regions of interest, and construction of colored diffusion maps 
(e.g. FA maps). The DTI images were analyzed using the diffu-
sion toolbox that accompanies the FSL 4.1 software (http://
www.fmrib.ox.ac.uk/fsl)18. Images were evaluated for Eddy 
current  correction distortion and brain extraction, and FA 
images were created for all subjects via diffusion tensor calcu-
lation. Individual FA maps were registered using a non-linear 
algorithm, which uses a b-spline representation of the regis-
tration warp field19. The FMRIB58 standard-space was used as 
reference (target) for the registration (http://www.fmrib.ox.ac.
uk/fsl/data/FMRIB58_FA.html). Next, an average FA image of 
all individuals was created and from this, an average FA skel-
eton, representing the center of all tracts that a group had in 
common, was constructed. Individual FA images were then 
aligned and projected onto this skeleton to obtain a resulting 
image that was used to perform voxel-wise statistics between 
individuals; FA > 0.3 was used to exclude peripheral tracts due 
to significant variability among individuals.
Statistical method
Voxel-wise statistical analysis of FA images was per-
formed using tract-based spatial statistics (TBSS)20, which 
is part of the FSL  4.1 software. To produce significance 
maps, a voxel-wise analysis was performed using infer-
ence based on permutations (5,000 permutations) and 
threshold-free-cluster-enhancement. The significance level 
was set at p < 0.05 and corrected by multiple comparisons 
( family-wise error). Maps of significance “p” were generated 
to identify differences in areas of FA between patients with 
HD, presymptomatic individuals, and controls. 
Green outlines showed the areas used for statistical anal-
ysis. After obtaining white matter integrity data,  we com-
pared FA values across the three groups.
RESULTS
We found a statistically significant reduction in FA val-
ues of the symptomatic HD group when compared with pres-
ymptomatic and control individuals. Tracts affected were the 
genu, truncus, and splenium of the corpus callosum, fornix, 
corticospinal tract, anterior and posterior corona radiate, 
anterior and posterior thalamic radiations, external capsule, 
inferior longitudinal fasciculus, and inferior fronto-occipital 
fasciculus. The superior longitudinal and uncinate fasciculus 
presented a reduction of FA in the HD group, but only when 
these values were compared to controls and not presymp-
tomatic participants.  Figures 1 and 2 show the tracts that 
displayed a reduction of FA, in yellow.
There was no statistically significant difference between 
the presymptomatic and the control group.
DISCUSSION
White matter degeneration  is increasingly being pos-
tulated as  an important feature in the progression of HD. 
The use of innovative imaging techniques, such as DTI 
with TBSS and tractography, allow for a more accurate and 
detailed analysis of the progression of white matter degener-
ation, and can provide valuable information, even before an 
established HD diagnosis. The HD mutation can affect neuro-
nal development, leading to structural differences and diffu-
sion abnormalities. However, previous studies have revealed 
that changes in diffusivity and FA are correlated with clini-
cal severity and cognitive performance, and individuals with 
established HD exhibit more extensive alterations than those 
in presymptomatic stages of the disease6,21. Taken together, 
these studies indicate that HD pathology involves progres-
sive structural degeneration.
Our data showed degeneration of many white mat-
ter tracts in patients with HD when compared to controls and 
presymptomatic individuals; however, we could not demon-
strate differences between the presymptomatic and the con-
trol groups. Our results are different from what we expected 
and may have been biased because of the small sample size 
or  because of the 1.5T technique used;  studies with a 3-T 
scanner are necessary to clarify this issue. Alternatively, this 
could indicate that degenerative processes start concomi-
tant to the development of symptoms. 
In the current study, we used  the TBSS  statistical 
test to overcome difficulties in aligning diffusion data across 
subjects. Using this approach allowed us to conduct an objec-
tive voxel-wise analysis of regional changes in brain-wide 
white matter. One disadvantage of this method is that 
smaller lesions may not have been captured due to alignment 
issues. However, this study was not the first to use diffusion 
imaging methods in presymptomatic patients with HD. For 
instance, increased diffusion has been observed in carriers 
of the mutant HD gene in periventricular and striatal white 
matter22. Another study that applied a voxel-based analysis on 
presymptomatic individuals showed a decrease in white mat-
ter FA in the superior frontal, medial frontal, postcentral, and 
precentral regions6. Rosas et al.6, using a manually-adjusted 
region of interest, demonstrated a reduction of FA in the cor-
ticospinal tract and corpus callosum in presymptomatic indi-
viduals with HD. Moreover, Stoffers et al.23 used tractography 
to assess modifications in both gray matter and white mat-
ter in presymptomatic subjects, and showed a decrease in 
the volume of both. More specifically, they reported a change 
in gray matter specific to the basal ganglia–thalamocortical 
pathways, but a more widespread deterioration of white 
matter. In accordance with abnormalities found in the gray 
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Figure 2. Huntington disease patients versus presymptomatic individuals. Yellow areas show a significant reduction of fractional 
anisotropy in patients with Huntington disease compared to that in presymptomatic partients (p < 0.05). Tracts with reduced 
fractional anisotropy: genu, truncus, and splenium of the corpus callosum; anterior and posterior corona radiate; and inferior 
fronto-occipital fasciculus.
Figure 1. Huntington disease patients versus control individuals. Yellow areas show a significant reduction of fractional anisotropy 
in patients with Huntington disease compared to that in controls (p < 0.05). Tracts with reduced fractional anisotropy: genu, truncus, 
and splenium of the corpus callosum; fornix; corticospinal tract; anterior and posterior corona radiate; anterior and posterior 
thalamic radiations; external capsule; uncinate fasciculus; inferior longitudinal fasciculus; and inferior fronto-occipital fasciculus.
matter (in areas such as the motor cortex), the TBSS analysis 
conducted by Stoffers et al.23 showed that presymptomatic 
individuals exhibited reduced anisotropy in the major out-
put of the corticospinal tract. However, they reported exten-
sive white matter changes, such as those involving the supe-
rior and inferior longitudinal fasciculus, and these regions do 
not relate to the loci of the gray matter change. This suggests 
that the loss of white matter tract integrity is not merely a 
consequence of gray matter atrophy. Finally, when a cor-
relation analysis was performed on the FA and “estimated 
years to symptom onset”, Stoffers et al.23 reported a more 
reduced FA value in presymptomatic subjects closest to the 
“estimated onset”. Although we used similar image acquisi-
tion techniques, we did not longitudinally examine the time 
of symptom onset in presymptomatic subjects, which might 
explain why we did not find statistically significant differ-
ences when comparing presymptomatic individuals with 
control subjects.
A study conducted by Novak et al.24 reported reduced 
white matter FA in presymptomatic and HD groups com-
pared to controls. Their analysis revealed that the greatest 
FA reductions occur in the bilateral corpus callosum, cingu-
lum, superior and inferior longitudinal fasciculi, short perfo-
rating fibers, and internal and external capsules. The authors 
observed that there was an extensive area of compromised 
white matter in individuals with HD and that these altered 
diffusivity parameters could serve as markers of disease 
severity.  Novak et al. also evaluated white matter AD  and 
caudate nucleus volume and postulated that white matter 
microstructural alterations in individuals with HD are related 
to changes in caudate nucleus volume and in the white mat-
ter  tracts directly related to this nucleus. Further, it is pos-
sible that white matter degeneration occurs as a direct result 
of caudate nucleus atrophy.  Our current data support  the 
hypothesis that the degeneration of white matter micro-
structures precedes macroscopic changes (volumetric)24.
Another study,  using DTI, evaluated and compared FA, 
AD, and diffusivity of perpendicular and parallel fibers and 
showed a significant reduction in FA and increase in AD in 
patients with HD compared to controls. These changes were 
specific to the corpus callosum, fornix, external and internal 
capsules, corona radiate, and sagittal stratum. In addition, the 
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FA was significantly reduced in the left posterior thalamic radi-
ation and left superior longitudinal fasciculus. Abnormalities 
in the corticospinal and interhemispheric tracts affect motor 
and cognitive functions in individuals with HD. 
The interhemispheric connection between the sensory 
and motor cortex through the corpus callosum is crucial for 
coordinated movement. Of equal importance are prefron-
tal regions that are interconnected with the corpus callosum, 
as their impairment could have negative consequences on 
cognitive function25. Rosas et al.6 showed  that presymptom-
atic patients can be differentiated from controls based on 
the FA value that corresponds to the genu of the corpus cal-
losum25. The microstructure of the corpus callosum has also 
been shown to be involved in the clinical symptoms of HD, 
as Rosas et al.6 demonstrated reduced FA values in the genu, 
truncus, and splenium of patients with HD, while presymp-
tomatic individuals only exhibited reduced FA in the truncus 
of the corpus callosum6. The corpus callosum has been thor-
oughly studied in HD, since it is the main area of information 
transfer between the brain hemispheres and is involved in 
executive function and non-spatial working memory, both of 
which are deficient in presymptomatic individuals. Moreover, 
diffusion abnormalities in the corpus callosum may represent 
pathological changes in the cerebral cortex8. Our current work 
showed involvement of the corpus callosum; thus, microstruc-
tural changes in the corpus callosum could prove a promis-
ing  target to better understand how alterations in this tract 
correlate with HD-related cognitive and motor changes. 
Longitudinal analyses using DTI with TBSS are promising 
to improve our understanding of the progression of HD. In fact, 
a study that employed the TBSS technique on a relatively small 
sample size was the first to suggest longitudinal white mat-
ter degeneration in individuals with HD26. A recent study on 
a larger sample aimed to quantify changes in white matter 
microstructures in presymptomatic patients and patients with 
HD before and after an 18-month period27. This study showed a 
reduction of FA in the corpus callosum and in the cingulum of 
presymptomatic individuals compared with individuals with 
HD. Moreover, the reduced FA of the genu, truncus, and sple-
nium of  the corpus callosum is significantly  correlated with 
motor scores of the Unified Huntington’s Disease Rating Scale 
in both HD groups. This measure is also the only independent 
predictor of a longitudinal decline in FA in all parts of the cor-
pus callosum in both HD groups, suggesting that the loss of 
axonal integrity is an early indication of neurodegenerative 
changes. Although the abovementioned study revealed no lon-
gitudinal changes in presymptomatic individuals, the clinical 
symptoms and alterations in motor function predicted impor-
tant microstructural white matter changes for all individuals 
genetically positive for HD. Thus, use of the TBSS to measure 
FA in the current study enabled us to analyze specific path-
ways of interest with more accuracy, providing greater cred-
ibility to our results, and allowing us to suitably observe white 
matter microstructure and connection changes.
In conclusion, by using the DTI technique, HD patients 
exhibited extensively impaired white matter tracts, leading 
us to propose that changes in the diffusion parameters were 
associated with markers of the severity of the disease. On the 
other hand, we could not identify abnormalities in the pres-
ymptomatic phase of HD and further studies are necessary to 
identify whether DTI is a useful tool for the follow-up of the 
degenerative process of HD. 
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